Author

Tao Lin

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Peri-transplant eculizumab for preventing antibody-mediated rejection in kidney transplant recipients at high immunologic risk: a systematic review with design-stratified evidence synthesis

Highly sensitized candidates, preformed donor-specific antibodies, and ABO incompatibility restrict access to kidney transplantation and increase antibody-mediated rejection (AMR) risk. We systematically evaluated peri-transplant eculizumab-containing prophylaxis in high-immunologic-risk kidney transplantation....

Cheng-Ze Liang, Rong Bao, Sai-Fu Yin et al. · Frontiers in Immunology · 0 citations

Review Oct 2026

Post-Nephrectomy Renal Outcomes in Living Kidney Donors with Diabetes and Prediabetes: A Retrospective Cohort Study.

BACKGROUND Kidney transplantation is the optimal treatment for end-stage renal disease (ESRD), but the persistent donor shortage necessitates expanding the donor pool, including utilizing living donors with dysglycemia. However, their post-nephrectomy safety remains inadequately characterized. METHODS This retrospect...

Sai-Fu Yin, Yan Zhou, Wen-Xia Huang et al. · JN. Journal of Nephrology (M... · 0 citations

Open access Sep 2026

B3GALT5 regulates renal A/B antigen levels: a determinant of prognosis and rejection in ABO-incompatible kidney transplantation

Background ABO-incompatible (ABOi) kidney transplantation alleviates the shortage of donor kidneys. However, interventions targeting blood group antibodies alone cannot fully prevent antibody-mediated rejection. We investigated how blood group antigens affect prognosis and rejection in ABOi kidney transplantation and e...

Fan Zhang, Sai-Fu Yin, Yang Xiong et al. · Journal of Global Health · 0 citations